Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 685 to 691 of 691 entries
Sorted by: Best Match Show Resources per page
SECRET.

Andrology

Zaccaro C, Lotti F, Morselli S, Sebastianelli A, Frizza F, Bigazzi B, Liaci A, Cai T, Vignozzi L, Vignolini G, Serni S, Gravas S, Moncada I, Salonia A, Gacci M.
PMID: 33275841
Andrology. 2021 May;9(3):878-885. doi: 10.1111/andr.12955. Epub 2020 Dec 17.

BACKGROUND: Recording the entire sexual history of a patient from the very first sexual experiences to the current sexual habits is a challenging issue that physicians usually address with partial and non-standardized interviews.OBJECTIVES: To validate the SExual Chronicle REcording...

Cite
Zaccaro C, Lotti F, Morselli S, et al. SECRET. Andrology. 2020;9(3):878-885doi: 10.1111/andr.12955.
Zaccaro, C., Lotti, F., Morselli, S., Sebastianelli, A., Frizza, F., Bigazzi, B., Liaci, A., Cai, T., Vignozzi, L., Vignolini, G., Serni, S., Gravas, S., Moncada, I., Salonia, A., & Gacci, M. (2021). SECRET. Andrology, 9(3), 878-885. https://doi.org/10.1111/andr.12955
Zaccaro, Claudia, et al. "SECRET." Andrology vol. 9,3 (2021): 878-885. doi: https://doi.org/10.1111/andr.12955
Zaccaro C, Lotti F, Morselli S, Sebastianelli A, Frizza F, Bigazzi B, Liaci A, Cai T, Vignozzi L, Vignolini G, Serni S, Gravas S, Moncada I, Salonia A, Gacci M. SECRET. Andrology. 2021 May;9(3):878-885. doi: 10.1111/andr.12955. Epub 2020 Dec 17. PMID: 33275841.
Copy Download .nbib Format: NLM
The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology

Gacci M, Greco I, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti G, Corvò R, De Nunzio C, Fusco F, Graziotti P, Maggi S, Magrini SM, Mirone V, Montironi R, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Salonia A, Simonato A, Serni S, Tubaro A, Zagonel V, Crepaldi G.
PMID: 33200896
Minerva Urol Nefrol. 2020 Nov 17; doi: 10.23736/S0393-2249.20.03925-9. Epub 2020 Nov 17.

BACKGROUND: Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, there's no certain indication about the maximum waiting time (WT) acceptable for treatment beginning and the impact on oncological and functional outcomes has not...

Cite
Gacci M, Greco I, Artibani W, et al. The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study. Minerva Urol Nefrol. 2020;doi: 10.23736/S0393-2249.20.03925-9.
Gacci, M., Greco, I., Artibani, W., Bassi, P., Bertoni, F., Bracarda, S., Briganti, A., Carmignani, G., Carmignani, L., Conti, G., Corvò, R., De Nunzio, C., Fusco, F., Graziotti, P., Maggi, S., Magrini, S. M., Mirone, V., Montironi, R., Muto, G., Noale, M., Pecoraro, S., Porreca, A., Ricardi, U., Russi, E., Salonia, A., Simonato, A., Serni, S., Tubaro, A., Zagonel, V., Crepaldi, G. (2020). The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, . https://doi.org/10.23736/S0393-2249.20.03925-9
Gacci, Mauro, et al. "The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study." Minerva urologica e nefrologica = The Italian journal of urology and nephrology vol. (2020). doi: https://doi.org/10.23736/S0393-2249.20.03925-9
Gacci M, Greco I, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti G, Corvò R, De Nunzio C, Fusco F, Graziotti P, Maggi S, Magrini SM, Mirone V, Montironi R, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Salonia A, Simonato A, Serni S, Tubaro A, Zagonel V, Crepaldi G. The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study. Minerva Urol Nefrol. 2020 Nov 17; doi: 10.23736/S0393-2249.20.03925-9. Epub 2020 Nov 17. PMID: 33200896.
Copy Download .nbib Format: NLM
Clinica: An Open-Source Software Platform for Reproducible Clinical Neuroscience Studies.

Frontiers in neuroinformatics

Routier A, Burgos N, Díaz M, Bacci M, Bottani S, El-Rifai O, Fontanella S, Gori P, Guillon J, Guyot A, Hassanaly R, Jacquemont T, Lu P, Marcoux A, Moreau T, Samper-González J, Teichmann M, Thibeau-Sutre E, Vaillant G, Wen J, Wild A, Habert MO, Durrleman S, Colliot O.
PMID: 34483871
Front Neuroinform. 2021 Aug 13;15:689675. doi: 10.3389/fninf.2021.689675. eCollection 2021.

We present Clinica (www.clinica.run), an open-source software platform designed to make clinical neuroscience studies easier and more reproducible. Clinica aims for researchers to (i) spend less time on data management and processing, (ii) perform reproducible evaluations of their methods,...

Cite
Routier A, Burgos N, Díaz M, et al. Clinica: An Open-Source Software Platform for Reproducible Clinical Neuroscience Studies. Front Neuroinform. 2021;15:689675doi: 10.3389/fninf.2021.689675.
Routier, A., Burgos, N., Díaz, M., Bacci, M., Bottani, S., El-Rifai, O., Fontanella, S., Gori, P., Guillon, J., Guyot, A., Hassanaly, R., Jacquemont, T., Lu, P., Marcoux, A., Moreau, T., Samper-González, J., Teichmann, M., Thibeau-Sutre, E., Vaillant, G., Wen, J., Wild, A., Habert, M. O., Durrleman, S., & Colliot, O. (2021). Clinica: An Open-Source Software Platform for Reproducible Clinical Neuroscience Studies. Frontiers in neuroinformatics, 15689675. https://doi.org/10.3389/fninf.2021.689675
Routier, Alexandre, et al. "Clinica: An Open-Source Software Platform for Reproducible Clinical Neuroscience Studies." Frontiers in neuroinformatics vol. 15 (2021): 689675. doi: https://doi.org/10.3389/fninf.2021.689675
Routier A, Burgos N, Díaz M, Bacci M, Bottani S, El-Rifai O, Fontanella S, Gori P, Guillon J, Guyot A, Hassanaly R, Jacquemont T, Lu P, Marcoux A, Moreau T, Samper-González J, Teichmann M, Thibeau-Sutre E, Vaillant G, Wen J, Wild A, Habert MO, Durrleman S, Colliot O. Clinica: An Open-Source Software Platform for Reproducible Clinical Neuroscience Studies. Front Neuroinform. 2021 Aug 13;15:689675. doi: 10.3389/fninf.2021.689675. eCollection 2021. PMID: 34483871; PMCID: PMC8415107.
Copy Download .nbib Format: NLM
Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases.

Antioxidants (Basel, Switzerland)

Bacci A, Runfola M, Sestito S, Rapposelli S.
PMID: 33671015
Antioxidants (Basel). 2021 Feb 28;10(3). doi: 10.3390/antiox10030367.

The complex network of malfunctioning pathways occurring in the pathogenesis of neurodegenerative diseases (NDDs) represents a huge hurdle in the development of new effective drugs to be used in therapy. In this context, redox reactions act as crucial regulators...

Cite
Bacci A, Runfola M, Sestito S, et al. Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases. Antioxidants (Basel). 2021;10(3)doi: 10.3390/antiox10030367.
Bacci, A., Runfola, M., Sestito, S., & Rapposelli, S. (2021). Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases. Antioxidants (Basel, Switzerland), 10(3), . https://doi.org/10.3390/antiox10030367
Bacci, Andrea, et al. "Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases." Antioxidants (Basel, Switzerland) vol. 10,3 (2021). doi: https://doi.org/10.3390/antiox10030367
Bacci A, Runfola M, Sestito S, Rapposelli S. Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases. Antioxidants (Basel). 2021 Feb 28;10(3). doi: 10.3390/antiox10030367. PMID: 33671015; PMCID: PMC7997428.
Copy Download .nbib Format: NLM
Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial.

BJS open

Carrano FM, Maroli A, Carvello M, Foppa C, Sacchi M, Crippa J, Clerico G, De Lucia F, Coppola E, Ben David N, Spinelli A.
PMID: 34904647
BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab116.

BACKGROUND: Stoma-reversal surgery is associated with high postoperative morbidity, including wound complications and surgical-site infections (SSIs). This study aims to assess whether the application of negative-pressure wound therapy (NPWT) can improve wound healing compared with conventional wound dressing.METHODS: This...

Cite
Carrano FM, Maroli A, Carvello M, et al. Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial. BJS Open. 2021;5(6)doi: 10.1093/bjsopen/zrab116.
Carrano, F. M., Maroli, A., Carvello, M., Foppa, C., Sacchi, M., Crippa, J., Clerico, G., De Lucia, F., Coppola, E., Ben David, N., & Spinelli, A. (2021). Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial. BJS open, 5(6), . https://doi.org/10.1093/bjsopen/zrab116
Carrano, Francesco M, et al. "Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial." BJS open vol. 5,6 (2021). doi: https://doi.org/10.1093/bjsopen/zrab116
Carrano FM, Maroli A, Carvello M, Foppa C, Sacchi M, Crippa J, Clerico G, De Lucia F, Coppola E, Ben David N, Spinelli A. Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial. BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab116. PMID: 34904647.
Copy Download .nbib Format: NLM
Theoretical and experimental study on the O(.

Physical chemistry chemical physics : PCCP

Giustini A, Aschi M, Park H, Meloni G.
PMID: 34296711
Phys Chem Chem Phys. 2021 Sep 15;23(35):19424-19434. doi: 10.1039/d1cp01724a.

In this work we report a joint experimental and computational study on the 2,5-dimethylfuran oxidation reaction in the gas phase initiated by atomic oxygen O(

Cite
Giustini A, Aschi M, Park H, et al. Theoretical and experimental study on the O(. Phys Chem Chem Phys. 2021;23(35):19424-19434doi: 10.1039/d1cp01724a.
Giustini, A., Aschi, M., Park, H., & Meloni, G. (2021). Theoretical and experimental study on the O(. Physical chemistry chemical physics : PCCP, 23(35), 19424-19434. https://doi.org/10.1039/d1cp01724a
Giustini, Andrea, et al. "Theoretical and experimental study on the O(." Physical chemistry chemical physics : PCCP vol. 23,35 (2021): 19424-19434. doi: https://doi.org/10.1039/d1cp01724a
Giustini A, Aschi M, Park H, Meloni G. Theoretical and experimental study on the O(. Phys Chem Chem Phys. 2021 Sep 15;23(35):19424-19434. doi: 10.1039/d1cp01724a. PMID: 34296711.
Copy Download .nbib Format: NLM
Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline.

Molecular psychiatry

Bucci M, Chiotis K, Nordberg A.
PMID: 34593971
Mol Psychiatry. 2021 Oct;26(10):5888-5898. doi: 10.1038/s41380-021-01263-2. Epub 2021 Oct 01.

For early detection of Alzheimer's disease, it is important to find biomarkers with predictive value for disease progression and clinical manifestations, such as cognitive decline. Individuals can now be profiled based on their biomarker status for Aβ42 (A) or...

Cite
Bucci M, Chiotis K, Nordberg A. Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Mol Psychiatry. 2021;26(10):5888-5898doi: 10.1038/s41380-021-01263-2.
Bucci, M., Chiotis, K., Nordberg, A. (2021). Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Molecular psychiatry, 26(10), 5888-5898. https://doi.org/10.1038/s41380-021-01263-2
Bucci, Marco, et al. "Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline." Molecular psychiatry vol. 26,10 (2021): 5888-5898. doi: https://doi.org/10.1038/s41380-021-01263-2
Bucci M, Chiotis K, Nordberg A. Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Mol Psychiatry. 2021 Oct;26(10):5888-5898. doi: 10.1038/s41380-021-01263-2. Epub 2021 Oct 01. PMID: 34593971.
Copy Download .nbib Format: NLM
Showing 685 to 691 of 691 entries